Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens

Privia Health Group (NASDAQ:PRVA - Get Free Report)'s stock had its "overweight" rating reissued by stock analysts at Stephens in a report issued on Thursday,Benzinga reports. They currently have a $26.00 price objective on the stock. Stephens' price target suggests a potential upside of 32.38% from the stock's previous close.

Several other research firms have also weighed in on PRVA. KeyCorp began coverage on Privia Health Group in a research report on Friday, October 11th. They issued an "overweight" rating and a $23.00 price objective for the company. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective on the stock. Barclays raised their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a research report on Friday, November 8th. Truist Financial boosted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $24.88.

Privia Health Group Stock Performance

Shares of PRVA traded up $0.09 during mid-day trading on Thursday, reaching $19.64. 395,241 shares of the company were exchanged, compared to its average volume of 832,075. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $23.78. The business has a 50 day simple moving average of $20.62 and a two-hundred day simple moving average of $19.28. The stock has a market capitalization of $2.36 billion, a PE ratio of 196.42, a PEG ratio of 5.45 and a beta of 0.83.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC lifted its stake in Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company's stock valued at $330,858,000 after purchasing an additional 271,645 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Privia Health Group by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after buying an additional 23,178 shares during the last quarter. Franklin Resources Inc. grew its stake in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock worth $23,092,000 after acquiring an additional 28,480 shares during the period. Millennium Management LLC increased its holdings in Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company's stock worth $19,788,000 after acquiring an additional 1,101,730 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company's stock valued at $19,441,000 after acquiring an additional 173,934 shares during the period. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.